Showing results (621-630 of 1,402) with videos related to

Sort By:
Pageof 141
Pharmacology Research & Perspectives|July 24, 2023
Oral morphine induces spinal 5-hydroxytryptamine (5-HT) release using an opioid receptor-independent mechanismShingo Nakamura, Shuji Komatsu, Toshihiko Yamada, et al.
Pharmacology Research & Perspectives|July 20, 2023
Modeling time-delayed concentration-QT effects with ACT-1014-6470, a novel oral complement factor 5a receptor 1 (C5a1 receptor) antagonistMarion Anliker-Ort, Chih-Hsuan Hsin, Andreas Krause, et al.
Pharmacology Research & Perspectives|July 20, 2023
The potencies and neurotoxicity of intrathecal levobupivacaine in a rat spinal model: Effects of concentrationLuyue Gao, Zhen Yang, Sisi Zeng, et al.
Pharmacology Research & Perspectives|August 2, 2023
Intravenous ibuprofen in postoperative pain and fever management in adults: A systematic review and meta-analysis of randomized controlled trialsPengxiang Zhou, Lu Chen, Ente Wang, et al.
Pharmacology Research & Perspectives|August 7, 2023
Experimental training in molecular pharmacology education based on drug-target interactionsLuna Ge, Kai Cheng, Yuang Zhang, et al.
Pharmacology Research & Perspectives|July 27, 2023
How to approach a study in ethnopharmacology? Providing an example of the different research stages for newcomers to the field todayFabien Schultz, Leif-Alexander Garbe
Pharmacology Research & Perspectives|August 1, 2023
Could cannabinoids provide a new hope for ovarian cancer patients?Rimanee Kaur, Farideh A Javid
Pharmacology Research & Perspectives|August 24, 2023
Suspected oncologic adverse reactions associated with interleukin-23 inhibitors in EudraVigilance: Comparative study and gender distributionFabrizio Calapai, Carmen Mannucci, Luigi Cardia, et al.
Pharmacology Research & Perspectives|June 29, 2023
Role of efficacy as a determinant of locomotor activation by mu-opioid receptor (MOR) ligands in female and male mice. II. Effects of novel MOR-selective phenylmorphans with high-to-low MOR efficacyEdna J Santos, Nima Nassehi, Eric W Bow, et al.
Pharmacology Research & Perspectives|June 3, 2023
A phase I, first-in-human study investigating the safety, tolerability, and pharmacokinetics of the maturation inhibitor GSK3739937Paul D Benn, Ying Zhang, Lesley Kahl, et al.
Pageof 141